Tuberous Sclerosis

Disease Overview

Tuberous Sclerosis Complex (TSC) is a rare genetic disorder characterized by the growth of benign tumors in multiple organ systems, including the brain, skin, kidneys, heart, eyes, and lungs. The condition is typically lifelong and can vary significantly in severity between individuals, ranging from mild symptoms to more complex medical challenges.

Disease Category

Genetic Neurocutaneous Disorder - Autosomal Dominant Inheritance - Multisystem Developmental Disorder

Synonyms

Tuberous Sclerosis Complex (TSC)
Bourneville Disease
Bourneville-Pringle Disease

Signs & Symptoms

Neurological: - Seizures - Developmental delays - Intellectual disability - Autism spectrum disorder - Cortical tubers - Subependymal nodules

Dermatological: - Hypomelanotic macules - Facial angiofibromas - Shagreen patches - Ungual fibromas

Systemic: - Kidney angiomyolipomas - Cardiac rhabdomyomas - Pulmonary lymphangioleiomyomatosis - Retinal hamartomas - Dental enamel pits

Causes

Genetic Mutations: - TSC1 gene mutations (chromosome 9) - TSC2 gene mutations (chromosome 16) - Mutations affect proteins hamartin and tuberin - Disrupts cell growth regulation and mTOR pathway - Can be inherited or occur as spontaneous mutations

Affected Populations

Incidence: 1 in 6,000-10,000 live births
Affects all ethnic groups and genders equally
No significant gender or racial predisposition
Can occur in any family background

Disorders with Similar Symptoms

Neurofibromatosis
Sturge-Weber syndrome
Von Hippel-Lindau disease
PTEN hamartoma syndrome

Diagnosis

Diagnostic Criteria: - Comprehensive clinical evaluation - Genetic testing for TSC1/TSC2 mutations - Neuroimaging (MRI, CT scans) - Echocardiograms - Renal ultrasounds - Dermatological assessment - Ophthalmological examination

Standard Therapies

Multidisciplinary Management: - Antiepileptic medications - mTOR inhibitors (everolimus) - Behavioral therapy - Educational interventions - Surgical tumor removal - Symptomatic treatment - Regular monitoring

Clinical Trials and Studies

Research Focus Areas: - Genetic therapies - mTOR pathway interventions - Tumor management strategies - Neurological symptom control

Resources: - ClinicalTrials.gov - NIH Clinical Trials Database

References

Genetics in Medicine (official journal)
Journal of Child Neurology
American Journal of Medical Genetics

Programs & Resources

Tuberous Sclerosis Alliance
National Organization for Rare Disorders (NORD)
The LAM Foundation
Epilepsy Foundation
National Institutes of Health (NIH)

Complete Report

Comprehensive medical documentation available through specialized genetic and neurodevelopmental research centers, providing in-depth analysis of Tuberous Sclerosis Complex, its management, and ongoing research efforts.